Biosimilars: not just a generic

New biosimilars are set to flood into the Australian market over the next several years as patents on biologics expire… but significant concerns remain about switching A steep learning curve is likely for community pharmacists, who to date have had comparatively little involvement in the substitution of biosimilars, as since they began to enter the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacists pulled up on regulatory infractions
Next What do you think of the government response on homeopathy?